Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2003
Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trialsGregory A Wiseman, Ellen Kornmehl, Bryan Leigh, et al.
Clinical Lymphoma & Myeloma|November 21, 2007
Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphomaGregory A Wiseman, Peter S Conti, Katie Vo, et al.
Leukemia & Lymphoma|March 15, 2017
Accuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma - tissue remains the issueAnthony Q Pham, Stephen M Broski, Thomas M Habermann, et al.
Thyroid : Official Journal of the American Thyroid Association|July 18, 2008
18F-FDG PET in the management of patients with anaplastic thyroid carcinomaTrond Velde Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2007
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid glandDimitrios Karantanis, Trond V Bogsrud, Gregory A Wiseman, et al.
Nuclear Medicine Communications|September 29, 2007
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patientsDimitrios Karantanis, Brian P O'eill, Rathan M Subramaniam, et al.
Leukemia & Lymphoma|November 30, 2013
Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphomaMichael J Conte, Deborah A Bowen, Gregory A Wiseman, et al.
Cancer|March 6, 2002
Radiation dosimetry results for Zevalin radioimmunotherapy of rituximab-refractory non-Hodgkin lymphomaGregory A Wiseman, Bryan Leigh, William D Erwin, et al.
American Journal of Hematology|May 15, 2014
The utility of restaging bone marrow biopsy in PET-negative patients with diffuse large B-cell lymphoma and baseline bone marrow involvementAmie E Jackson, Jacob P Smeltzer, Thomas M Habermann, et al.
Nuclear Medicine Communications|February 1, 2011
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodiesTrond Velde Bogsrud, Ian D Hay, Dimitrios Karantanis, et al.
Pageof 6